Upgrade to SI Premium - Free Trial

Teva Pharma (TEVA) PT Raised to $52 at Oppenheimer

October 9, 2026 12:03 PM
(Updated - October 9, 2026 12:04 PM EDT)

Oppenheimer analyst Les Sulewski raised the price target on Teva Pharma ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change